Artículos por temáticas

Additional use of Aβ₄₂/Aβ₄₀ ratio with cerebrospinal fluid biomarkers P-tau and Aβ₄₂ increases the level of evidence of Alzheimer's disease pathophysiological process in routine practice

Sauvée M, DidierLaurent G, Latarche C, Escanyé MC, Olivier JL, Malaplate-Armand C.

J Alzheimers Dis. 2014;41(2):377-86. doi: 10.3233/JAD-131838.

Plasma phospholipids identify antecedent memory impairment in older adults

Mapstone M, Cheema AK, Fiandaca MS, Zhong X, Mhyre TR, MacArthur LH, Hall WJ, Fisher SG, Peterson DR, Haley JM, Nazar MD, Rich SA, Berlau DJ, Peltz CB, Tan MT, Kawas CH, Federoff HJ.

Nat Med. 2014 Apr;20(4):415-8. doi: 10.1038/nm.3466. Epub 2014 Mar 9.

Variance in the identification of microRNAs deregulated in Alzheimer's disease and possible role of lincRNAs in the pathology: the need of larger datasets

Lau P, Frigerio CS, De Strooper B.

Ageing Res Rev. 2014 Sep;17:43-53. doi: 10.1016/j.arr.2014.02.006. Epub 2014 Mar 4.

Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014

Schneider LS, Mangialasche F, Andreasen N, Feldman H, Giacobini E, Jones R, Mantua V, Mecocci P, Pani L, Winblad B, Kivipelto M.

J Intern Med. 2014 Mar;275(3):251-83. doi: 10.1111/joim.12191.

Harmonized diagnostic criteria for Alzheimer's disease: recommendations

Morris JC, Blennow K, Froelich L, Nordberg A, Soininen H, Waldemar G, Wahlund LO, Dubois B.

J Intern Med. 2014 Mar;275(3):204-13. doi: 10.1111/joim.12199.

Electroanalytical and surface plasmon resonance sensors for detection of breast cancer and Alzheimer's disease biomarkers in cells and body fluids

Yang M, Yi X, Wang J, Zhou F.

Analyst. 2014 Apr 21;139(8):1814-25. doi: 10.1039/c3an02065g.

Detection of retinal nerve fiber layer degeneration in patients with Alzheimer's disease using optical coherence tomography: searching new biomarkers

Bambo MP, Garcia-Martin E, Pinilla J, Herrero R, Satue M, Otin S, Fuertes I, Marques ML, Pablo LE.

Acta Ophthalmol. 2014 Nov;92(7):e581-2. doi: 10.1111/aos.12374. Epub 2014 Mar 4.

Diffusion tensor imaging of white matter degeneration in Alzheimer's disease and mild cognitive impairment

Amlien IK, Fjell AM.

Neuroscience. 2014 Sep 12;276:206-15. doi: 10.1016/j.neuroscience.2014.02.017. Epub 2014 Feb 27.

Epigenetic dysregulation in Alzheimer's disease: cause or consequence?

van den Hove DL, Kenis G, Rutten BP.

Epigenomics. 2014 Feb;6(1):9-11. doi: 10.2217/epi.13.84.

The impact of surgery and anesthesia on post-operative cognitive decline and Alzheimer's disease development: biomarkers and preventive strategies

Kapila AK, Watts HR, Wang T, Ma D.

J Alzheimers Dis. 2014;41(1):1-13. doi: 10.3233/JAD-132258.

Lipidomics of Alzheimer's disease

Touboul D, Gaudin M.

Bioanalysis. 2014 Feb;6(4):541-61. doi: 10.4155/bio.13.346.

Meta-analysis of peripheral blood apolipoprotein E levels in Alzheimer's disease

Wang C, Yu JT, Wang HF, Jiang T, Tan CC, Meng XF, Soares HD, Tan L.

PLoS One. 2014 Feb 18;9(2):e89041. doi: 10.1371/journal.pone.0089041. eCollection 2014.

A systematic review of biomarkers for disease progression in Alzheimer's disease

McGhee DJ, Ritchie CW, Thompson PA, Wright DE, Zajicek JP, Counsell CE.

PLoS One. 2014 Feb 18;9(2):e88854. doi: 10.1371/journal.pone.0088854. eCollection 2014.

Imaging biomarkers for amyloid: a new generation of probes and what lies ahead

Leuzy A, Zimmer ER, Bhat V, Rosa-Neto P, Gauthier S.

Int Psychogeriatr. 2014 May;26(5):703-7. doi: 10.1017/S1041610214000118. Epub 2014 Feb 13.

Soluble amyloid precursor proteins and secretases as Alzheimer's disease biomarkers

Perneczky R, Alexopoulos P, Kurz A.

Trends Mol Med. 2014 Jan;20(1):8-15. doi: 10.1016/j.molmed.2013.10.001.